Living Cell Technologies Limited
LVCLY · OTC
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $11,028 | $12,033 | $15,350 | $13,838 |
| - Cash | $3,108 | $3,622 | $4,111 | $3,086 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $7,919 | $8,410 | $11,239 | $10,752 |
| Revenue | – | $0 | $42 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | – | $0 | $42 | $0 |
| % Margin | – | – | 100% | – |
| EBITDA | – | -$1,149 | -$337 | -$930 |
| % Margin | – | – | -801.4% | – |
| Net Income | – | -$1,451 | -$801 | -$1,307 |
| % Margin | – | – | -1,906.7% | – |
| EPS Diluted | – | -0.009 | -0.005 | -0.01 |
| % Growth | – | -80% | 50% | – |
| Operating Cash Flow | – | -$1,009 | -$834 | -$1,152 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | -$1,009 | -$834 | -$1,152 |